Recall archive / FDA drug enforcement
Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA,... — FDA record D-0276-2024
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jan 12, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30
- Reason
- Failed Dissolution Specifications
- Classification
- Class II
- Recalling firm
- Golden State Medical Supply Inc.
- Quantity
- 108 bottles
- Agency-reported status
- Terminated
- Source record identifier
- D-0276-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: GS054862, Exp. Date 07/31/2025 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Illinois only
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Feb 7, 2024
- Recall initiation date
- Jan 12, 2024
- Center classification date
- Jan 29, 2024
- Termination date
- Mar 20, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.